| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.29 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.061 | 0.03 |